Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev & Strategy | Restricted stock units | 24.3K | $864K | $35.54 | Mar 5, 2025 | Direct |
AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev & Strategy | Stock options (right to buy) | 55.4K | Mar 5, 2025 | Direct | ||
CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23.7K | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 5, 2025 | 2 | $0 | 4 | Mar 7, 2025 | Chief Corp Dev & Strategy |
AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 5, 2025 | 0 | $0 | 3 | Mar 7, 2025 | Chief Corp Dev & Strategy |
CRGX | CARGO Therapeutics, Inc. | Jun 4, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 1 | $0 | 4 | Nov 13, 2023 | Director |
CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 0 | $0 | 3 | Nov 9, 2023 | Director |